Jennison Associates LLC Dyne Therapeutics, Inc. Transaction History
Jennison Associates LLC
- $155 Billion
- Q2 2024
A detailed history of Jennison Associates LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 1,327,222 shares of DYN stock, worth $46.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,327,222
Previous 1,207,551
9.91%
Holding current value
$46.8 Million
Previous $34.3 Million
36.62%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
203Shares Held
106MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$283 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$276 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$260 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$225 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$213 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.82B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...